MEDICINES FOR EUROPE

Tweet this page
<
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
>
Registration as it was on 20 May 2014
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

125,000€

Financial year: Jan 2012 - Jan 2013

Lobbyists (Full time equivalent)

None declared

Lobbyists with EP accreditation

1

High-level Commission meetings

79

Lobbying Costs over the years

  • Info

    European Generic medicines Association   (EGA)

    EU Transparency Register

    48325781850-28 First registered on 16 Jun 2009

    Goals / Remit

    The EGA is the official representative body of the European generic and biosimilar pharmaceutical industry, which is at the forefront of providing high-quality affordable medicines to millions of Europeans and stimulating competitiveness and innovation in the pharmaceutical sector.
    Formed in 1993, the EGA represents generic pharmaceutical companies and their subsidiaries from throughout Europe, either directly or through national associations. Companies represented within the EGA provide over 150,000 jobs in Europe. Cost-effective generic medicines save EU patients and healthcare systems over €35 billion each year, thus helping to ensure patient access to essential medicines and providing urgently needed budget headroom for the purchase of new and innovative treatments.
    The EGA plays an important consultative part in European healthcare policy-making and provides key educational role for its members. The EGA and its members work with European national governments and the EU institutions to develop affordable solutions for pharmaceutical care and to increase Europe’s competitive strength in the global pharmaceutical medicines market.

    The EGA and its member companies and associations support and promote:
    • The sustainability and competitiveness of the European generic and biosimilar medicines industry
    • European, national and regional measures which increase market access to generic and biosimilar medicines
    • The creation of a European regulatory and IP framework that ensures immediate access to the post-patent market for generic and biosimilar medicines
    • Global adoption of high quality EU-like standards for APIs, generic medicines and biosimilar medicines

    The EGA is a founding member of the International Generic Pharmaceutical Alliance (IGPA) and has NGO status with WHO.


    EGA Member Companies
    Actavis
    Alkaloid
    Alfred E. Tiefenbacher
    Apotex Europe
    Arrow Generics
    Combino Pharm
    Consilient Health Ltd
    EGIS Pharmaceuticals
    Farmoz
    Fresenius Kabi
    Gedeon Richter
    Helm
    Hospira
    Jadran Galenski Laboratorij
    Medochemie
    Mylan
    Ranbaxy Europe
    Sandoz
    Sopharma AD
    Stada
    TEVA Europe
    Zentiva

    EGA Affiliate Members
    Acino Pharma AG
    AMCo
    Anapharm Europe
    Billev Pharma
    BioGenerix
    Disphar
    Farmaprojects
    Glenmark Generics
    JSC "Farmak"
    Hetero
    PharOS

    National Associations Full Members
    AESEG (Spain)
    APOGEN (Portugal)
    AssoGenerici (Italy)
    BGMA (United Kingdom)
    BOGIN(Netherlands)
    FeBelGen(Belgium)
    GEMME (France)
    IEIS(Turkey)
    IGL (Denmark)
    Progenerika (Germany)
    PZPPF (Poland)
    SPMA (Slovenia)

    National Associations Affiliate Members
    APMGR (Romania)
    BGPharmA(Bulgaria)
    CAFF(Czech Republic)
    FGA(Finland)
    FGL(Sweden)
    Intergenerika(Switzerland)
    OEGV(Austria)

    Main EU files targeted

    Address

    Head Office
    RUE D'ARLON
    BRUSSELS 1000
    BELGIUM
  • People

    Total lobbyists declared

    None declared

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    1 accreditations were / are live (in bold) for the selected state of 20 May 2014

    Name Start date End Date
    Luca PROSDOCIMO 18 May 2023 17 May 2024
    Gabriele NICOTRA 19 Jan 2024 17 Jan 2025
    Raluca RADU 27 Jul 2023 26 Jul 2024
    Giuliana PENNISI 14 Sep 2023 13 Sep 2024
    Mr GABRIELE NICOTRA 19 Jan 2024 15 Apr 2024
    Ms Giuliana PENNISI 14 Sep 2023 15 Apr 2024
    Ms Raluca RADU 27 Jul 2023 15 Apr 2024
    Sophie DAGENS 27 Jul 2023 26 Jul 2024
    Mr Luca Prosdocimo 18 May 2023 15 Apr 2024
    Mr Adrian van den Hoven 10 Mar 2023 11 Mar 2024
    Ms Beata Katarzyna STEPNIEWSKA-KOOLEN 04 Mar 2023 11 Mar 2024
    Mr Sergio NAPOLITANO 21 Jan 2023 20 Jan 2024
    Mr GABRIELE NICOTRA 13 Jan 2023 13 Jan 2024
    Ms Giuliana PENNISI 15 Sep 2022 14 Sep 2023
    Mr Luca Prosdocimo 24 May 2022 18 May 2023
    Mr GABRIELE NICOTRA 21 Apr 2022 01 Jan 2023
    Mr Andrea PUCCI 20 Nov 2021 11 Sep 2022
    Maja SERCIC 18 Nov 2021 18 Nov 2022
    Riccardo BONANNI 29 Oct 2021 01 Mar 2022
    Ms Giuliana PENNISI 13 Sep 2021 14 Sep 2022
    Mr Sergio NAPOLITANO 24 Sep 2019 01 Oct 2020
    Giuliana PENNISI 13 Jul 2019 11 Jul 2020
    Mr Sergio NAPOLITANO 20 Sep 2018 20 Sep 2019
    Mr Andrea PUCCI 12 Sep 2018 01 Oct 2019
    Giuliana PENNISI 22 Jun 2018 22 Jun 2019
    Ms Giuliana PENNISI 18 May 2017 17 May 2018
    Ms Julie Chauvet 02 Apr 2016 22 Feb 2017
    Ms Julie Chauvet 26 Mar 2015 24 Mar 2016
    Ms Julie Chauvet 28 Mar 2014 26 Mar 2015
    Ms Julie Chauvet 20 Mar 2013 19 Mar 2014
    Ms Julie Chauvet 04 Apr 2012 20 Mar 2013

    Complementary Information

    None declared

    Person in charge of EU relations

    None declared

    Person with legal responsibility

    Mr Adrian Van den Hoven (DIRECTOR GENERAL)

  • Categories

    Category

    II - In-house lobbyists and trade/professional associations

    Subcategory

    Trade, business & professional associations

  • Networking

    Affiliation

    None declared

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2012 - Jan 2013

    Lobbying costs for closed financial year

    125,000€

    Other financial info

    The EGA has in 2012 financed in conjunction with 3 other member companies a chair at Katholieke Universiteit Leuven "European policy towards generic medicines".
    The Chair explores issues surrounding the European generic medicines industry and patient access to affordable healthcare, the effect of generic competition on healthcare budget.

  • EU Structures

    Groups (European Commission)

    None declared

    Groups (European Parliament)

    None declared

    Communication activities

    None declared

    Other activities

    None declared

  • Meetings

    Meetings

    79 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

Download this datacard